Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 4
2006 3
2007 7
2008 7
2009 2
2010 6
2011 4
2012 5
2013 4
2014 4
2015 5
2016 6
2017 8
2018 9
2019 9
2020 17
2021 16
2022 13
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Hormonal Therapy for Prostate Cancer.
Desai K, McManus JM, Sharifi N. Desai K, et al. Among authors: sharifi n. Endocr Rev. 2021 May 25;42(3):354-373. doi: 10.1210/endrev/bnab002. Endocr Rev. 2021. PMID: 33480983 Free PMC article. Review.
Androgen Signaling in Prostate Cancer.
Dai C, Heemers H, Sharifi N. Dai C, et al. Among authors: sharifi n. Cold Spring Harb Perspect Med. 2017 Sep 1;7(9):a030452. doi: 10.1101/cshperspect.a030452. Cold Spring Harb Perspect Med. 2017. PMID: 28389515 Free PMC article. Review.
Targeting the Androgen Signaling Axis in Prostate Cancer.
Dai C, Dehm SM, Sharifi N. Dai C, et al. Among authors: sharifi n. J Clin Oncol. 2023 Sep 10;41(26):4267-4278. doi: 10.1200/JCO.23.00433. Epub 2023 Jul 10. J Clin Oncol. 2023. PMID: 37429011 Review.
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis ES, Aparicio AM, Armstrong AJ, Attard G, Beer TM, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow RG, Bulbul M, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Chowdhury S, Clarke CS, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ngozi Ekeke O, Evans CP, Fanti S, Feng FY, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman MS, Horvath LG, Hussain M, Jereczek-Fossa BA, Jones R, Kanesvaran R, Kellokumpu-Lehtinen PL, Khauli RB, Klotz L, Kramer G, Leibowitz R, Logothetis CJ, Mahal BA, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Pezaro C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Rubin MA, Ryan CJ, Saad F, Pablo Sade J, Sartor OA, Scher HI, Sharifi N, Skoneczna I, Soule H, Spratt DE, Srinivas S, Sternberg CN, Steuber T, Suzuki H, Sydes MR, Taplin ME, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H,… See abstract for full author list ➔ Gillessen S, et al. Among authors: sharifi n. Eur Urol. 2023 Mar;83(3):267-293. doi: 10.1016/j.eururo.2022.11.002. Epub 2022 Dec 6. Eur Urol. 2023. PMID: 36494221 Free PMC article.
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M, Sweeney CJ, Tombal B, Antonarakis ES, Aparicio AM, Armstrong AJ, Attard G, Beer TM, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow RG, Bulbul M, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Chowdhury S, Clarke CS, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke ON, Evans CP, Fanti S, Feng FY, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman MS, Horvath LG, Hussain M, Jereczek-Fossa BA, Jones R, Kanesvaran R, Kellokumpu-Lehtinen PL, Khauli RB, Klotz L, Kramer G, Leibowitz R, Logothetis C, Mahal B, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Pezaro CJ, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Rubin MA, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Sharifi N, Skoneczna I, Soule H, Spratt DE, Srinivas S, Sternberg CN, Steuber T, Suzuki H, Sydes MR, Taplin ME, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H, Ürün Y, Va… See abstract for full author list ➔ Gillessen S, et al. Among authors: sharifi n. Eur J Cancer. 2023 May;185:178-215. doi: 10.1016/j.ejca.2023.02.018. Epub 2023 Mar 3. Eur J Cancer. 2023. PMID: 37003085 Free article.
Reply by Authors.
Lyon M, Li J, Cullen J, Milinovich A, Kattan M, Jehi L, Sharifi N, Klein EA. Lyon M, et al. Among authors: sharifi n. J Urol. 2022 Jan;207(1):189. doi: 10.1097/JU.0000000000002180.02. Epub 2021 Sep 30. J Urol. 2022. PMID: 34587771 No abstract available.
Sex Hormones and Prostate Cancer.
Auchus RJ, Sharifi N. Auchus RJ, et al. Among authors: sharifi n. Annu Rev Med. 2020 Jan 27;71:33-45. doi: 10.1146/annurev-med-051418-060357. Epub 2019 Oct 15. Annu Rev Med. 2020. PMID: 31613683 Review.
Targeting Glucocorticoid Metabolism in Prostate Cancer.
Valle S, Sharifi N. Valle S, et al. Among authors: sharifi n. Endocrinology. 2021 Sep 1;162(9):bqab132. doi: 10.1210/endocr/bqab132. Endocrinology. 2021. PMID: 34180973 Free PMC article. Review.
127 results